| [1] |
Lechat B, Appleton S, Melaku YA, et al. Comorbid insomnia and sleep apnoea is associated with all-cause mortality [J]. Eur Respir J, 2022, 60(1): 2101958.
|
| [2] |
Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnea: a literature-based analysis [J]. Lancet Respir Med, 2019, 7(8): 687-698.
|
| [3] |
国家卫生健康委高血压诊疗研究重点实验室学术委员会，国家卫生健康委高血压诊疗研究重点实验室，新疆维吾尔自治区人民医院高血压中心. 2023阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识[J]. 中华高血压杂志，2023, 31(12): 1142-1155.
|
| [4] |
阻塞性睡眠呼吸暂停合并代谢综合征诊疗专家共识组. 阻塞性睡眠呼吸暂停合并代谢综合征诊疗专家共识(2022)[J]. 中华耳鼻咽喉头颈外科杂志，2023, 58(2): 99-110.
|
| [5] |
郭文彬，刘玉璞，许华俊，等. 阻塞性睡眠呼吸暂停与代谢综合征：基于大样本临床数据库的相关性研究[J]. 中华耳鼻咽喉头颈外科杂志，2021, 56(12): 1263-1269.
|
| [6] |
何宇纳，赵文华，赵丽云，等. 中国2010-2012年成年人代谢综合征流行特征[J]. 中华流行病学杂志，2017, 38(2): 212-215.
|
| [7] |
Gleeson M, McNicholas WT. Bidirectional relationships of comorbidity with obstructive sleep apnoea [J]. Eur Respir Rev, 2022, 31(164): 210256.
|
| [8] |
Almendros I, Basoglu ÖK, Conde SV, et al. Metabolic dysfunction in OSA: Is there something new under the sun? [J]. J Sleep Res, 2022, 31(1): e13418.
|
| [9] |
Umbro I, Fabiani V, Fabiani M, et al. A systematic review on the association between obstructive sleep apnea and chronic kidney disease [J]. Sleep Med Rev, 2020, 53: 101337.
|
| [10] |
Turek NF, Ricardo AC, Lash JP. Mechanisms of cardiovascular disease in obstructive sleep apnea [J]. J Thorac Dis, 2018, 10(Suppl 34): S4201-S4211.
|
| [11] |
曾凌枫，张慧，雷思，等. 《成年人阻塞性睡眠呼吸暂停低通气综合征筛查：美国预防临床服务指南工作组推荐声明》解读[J]. 中国全科医学，2024, 27(12): 1412-1416.
|
| [12] |
李梦伊，罗樱樱，张鹏，等. 国家卫生健康委员会《肥胖症诊疗指南(2024年版)》解读[J]. 中华医学杂志，2025, 105(18): 1387-1391.
|
| [13] |
Kovesdy CP, Furth SL, Zoccali C, et al. Obesity and kidney disease: hidden consequences of the epidemic [J]. Kidney Int, 2017, 91(2): 260-262.
|
| [14] |
Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association [J]. Circulation, 2021, 144(3): e56-e67.
|
| [15] |
Jacobowitz O, Afifi L, Alkan U, et al. Endorsement of "European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea" by World Sleep Society [J]. Sleep Med, 2024, 113: 293-298.
|
| [16] |
Rahman Z, Nazim A, Mroke P, et al. Long-term management of sleep apnea-hypopnea syndrome: efficacy and challenges of continuous positive airway pressure therapy-a narrative review [J]. Med Sci (Basel), 2024, 13(1): 4.
|
| [17] |
Moriya R, Hokari S, Nicholl DDM, et al. Continuous positive airway pressure treatment reduces renal tubular damage in patients with obstructive sleep apnea: a retrospective single-center cohort study [J]. Sleep Med, 2023, 106: 106-115.
|
| [18] |
Costa IOM, Cunha MO, Bussi MT, et al. Impacts of conservative treatment on the clinical manifestations of obstructive sleep apnea-systematic review and meta-analysis [J]. Sleep Breath, 2024, 28(4): 1563-1574.
|
| [19] |
Launois C, Bailly S, Sabil A, et al. Association between healthy behaviors and health care resource use with subsequent positive airway pressure therapy adherence in OSA [J]. Chest, 2024, 166(4): 845-856.
|
| [20] |
Lajoie AC, Gu Y, Lim A, et al. Adherence to continuous positive airway pressure for the treatment of obstructive sleep apnea in neurodegenerative diseases: a systematic review [J]. Sleep Med Rev, 2023, 71: 101836.
|
| [21] |
Mansell SK, Devani N, Shah A, et al. Current treatment strategies in managing side effects associated with domiciliary positive airway pressure (PAP) therapy for patients with sleep disordered breathing: a systematic review and meta-analysis [J]. Sleep Med Rev, 2023, 72: 101850.
|
| [22] |
Fresnel E, Caillard C, Lebret M, et al. Comparison of oronasal and nasal masks in home mechanical ventilation: an observational cohort and bench study [J]. Eur Respir J, 2025, 65(1): 2302010.
|
| [23] |
Fridriksson B, Berndtson M, Hamnered H, et al. Beneficial effects of early intervention telemedicine-based follow-up in sleep apnea: a randomized controlled multicenter trial [J]. Ann Am Thorac Soc, 2023, 20(10): 1499-1507.
|